Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer

NCT01581970 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Cyclophosphamide
DRUG: Cetuximab

Sponsor

Masonic Cancer Center, University of Minnesota